nivolumab,ipilimumab,cabozantinib
bms
['rcc,(-irccs),(-srcc),(-urcc)', ' ipi ', '#gu,(-#gui),(-#gunagratinib),(-#guard),(-#gut)', 'cabo ', 'nivo', 'cosmic-313']
cosmic-313 -pfs benefit -50% any dose reductions
-70% g3-4 aes
-os not yet
#gu23 #medtwitter #kidney 
On the road!
Pursuing to improve global health through sharing knowledge, cancer prevention, and care.  
Medical oncologist @AnkaraUni